one-north represents Singapore's progress into a knowledge and innovation-intensive economy. It is a vibrant hotspot for research, innovation and test-bedding where you can live, work, learn and be inspired by leading scientists, researchers and technopreneurs from around the world.
one-north plays host to 3 purpose-built hubs to house key public and private institutes and organizations: Biopolis, the biomedical R&D facility; Fusionopolis, dedicated to R&D in the Infocomms, Media, Science and Engineering industries; Mediapolis, a self-contained digital media cluster.
The growth of these industries is supported by one-north's key infrastructural development. Within one-north, private-sector research labs are co-located with public-sector research institutes, tertiary hospitals and universities. Shared facilities reduce ramp-up time and promote collaboration between researchers in both private and public sectors.
The Biopolis is the hallmark of Singapore's R&D success. It co-locates public sector research institutes with corporate labs and is designed to foster a collaborative culture among the institutions and organisations under its roof. At Biopolis, scientists, technoprenuers and researchers meet, forge partnerships and grow with renowned scientific institutions, through intensive research and graduate training programmes.
The Biopolis enables researchers to access state-of-the-art facilities, scientific infrastructure and specialised services. These allow companies to cut R&D costs significantly and accelerate the development timeline. In addition, there are conference facilities and meeting rooms that companies can use. By 2013, the Biopolis will provide more than 3.3 million square feet of space for biomedical sciences R&D activities.
The Biopolis is strategically located next to the Kent Ridge Campus, where our public hospital and medical school are located, thereby facilitating translational and clinical research. The specialized research institutes in Kent Ridge include the Cancer Science Institute of Singapore, which is headed by Prof Daniel Tenen from Harvard. Leading companies such as AstraZeneca and Bayer Schering Pharma are partnering research units in the National University Health System at Kent Ridge for translational cancer research.
Fusionopolis is the first integrated work-live-play-learn development in one-north. Covering 30 hectares within one-north, the Fusionopolis cluster is developed in phases to introduce facilities, infrastructure and an environment conducive to growth in infocomm technology, media, physical sciences and engineering industries. Equipped with state-of-the-art infrastructure and facilities, this complex will provide the ideal environment to foster synergistic collaborations, experimentation and collaborations between the public and private research institutes.
A massive test-bed for new technologies, Fusionopolis Phase 2A is designed to house dry and wet laboratories, clean rooms and vibration sensitive test-bedding facilities. Phase 2A features Singapore's largest R&D clean room facility and provides 103,635 sqm of Business Park and R&D space when it is completed in 2014.
Mediapolis at one-north is a digital media capital where top quality content will be produced for international markets.
When completed, Mediapolis will house a media ecosystem of soundstages with green screen capabilities, including digital production and broadcast facilities and interactive digital media (IDM) and R&D activities, amongst an extensive range of other facilities and amenities. Its IT infrastructure and technology platform will draw media companies which rely on high-speed broadband connectivity to enable the processing, management and distribution of digital media content and services.
Award-winning local media production company, Infinite Frameworks (IFW), will invest, occupy, develop and build Singapore's first soundstage facility at Mediapolis.
